Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 10/20 | 0.44 |
| ▸ | CTSL | P07711 | 8/20 | 0.44 |
| ▸ | CTSB | P07858 | 4/20 | 0.44 |
| ▸ | CTSK | P43235 | 3/20 | 0.44 |
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7419135 | 0.88 | CTSS (0.45) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7420982 | 0.87 | CTSL (0.36) | CTSSCTSLCTSBCTSKALDH1A1 | |
| SCHEMBL7414874 | 0.85 | CTSS (0.46) | CTSSCTSLCTSBCTSKUSP30 | |
| SCHEMBL7014342 | 0.85 | CTSS (0.41) | CTSSALDH1A1KMT2AADRB1 | |
| SCHEMBL7414674 | 0.84 | CTSS (0.45) | CTSSCTSLCTSBCTSKUSP30 | |
| SCHEMBL7417228 | 0.83 | CTSL (0.44) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7422431 | 0.83 | CTSS (0.47) | CTSSCTSLCTSBCTSKALDH1A1 | |
| SCHEMBL7419241 | 0.77 | CTSL (0.43) | CTSSCTSLCTSBCTSKALDH1A1 | |
| SCHEMBL7417185 | 0.76 | CTSL (0.57) | CTSSCTSLCTSBCTSKUSP30 | |
| SCHEMBL7420985 | 0.75 | ALDH1A1 (0.43) | ALDH1A1KMT2AADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003529546-A | — | — | 2003-10-07 | — | — | JP | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | disclosed |